Metabolic abnormalities and survival among patients with non-metastatic breast cancer

Metabolic abnormalities and survival among patients with non-metastatic breast cancer

Abstract Background Research on the impact of metabolic abnormalities on breast cancer prognosis is limited by small samples and assessment of laboratory values at a single time point, often prior to cancer diagnosis and treatment. In this population-based cohort, time-updated laboratory values were...

Full description

Bibliographic Details
Main Authors: Alexa S. Zimbalist, Bette J. Caan, Wendy Y. Chen, Elizabeth A. Mittendorf, Deborah A. R. Dillon, Charles Quesenberry, Elizabeth M. Cespedes Feliciano
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cancer
Subjects:
Breast cancer
Metabolic dysregulation
Dyslipidemia
Hyperglycemia
Breast cancer survival
Prognosis
Online Access:https://doi.org/10.1186/s12885-022-10430-9

Internet

https://doi.org/10.1186/s12885-022-10430-9

Similar Items